After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Most recently, Yahoo Finance reported about the stock as it publicized that Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
INSM belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Insmed Inc is $4.06B. A total of 1.26 million shares were traded on the day, compared to an average of 1.63M shares.
In the most recent transaction, Adsett Roger sold 5,251 shares of INSM for 28.63 per share on Jan 12 ’24. After the transaction, the Chief Operating Officer now owns 148,559 company shares. In a previous transaction on Jan 12 ’24, Flammer Martina M.D. sold 4,667 shares at 28.63 per share. INSM shares that Chief Medical Officer owns now total 106,898.
Among the insiders who sold shares, Adsett Roger disposed of 3,536 shares on Jan 10 ’24 at a per-share price of $28.90. This resulted in the Chief Operating Officer holding 153,810 shares of INSM after the transaction. In another insider transaction, Flammer Martina M.D. sold 1,245 shares at $28.90 per share on Jan 10 ’24. Company shares held by the Chief Medical Officer now total 111,565.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, INSM has a high of $32.00 and a low of $16.25.
As of this writing, INSM has an earnings estimate of -$1.23 per share for the current quarter. EPS was calculated based on a consensus of 14 estimates, with a high estimate of -$1.11 per share and a lower estimate of -$1.38. The company reported an EPS of -$1.11 in the last quarter, which was 1.80% higher than expectations of -$1.13.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. INSM’s latest balance sheet shows that the firm has $716.78M in Cash & Short Term Investments as of fiscal 2021. There were $612.27M in debt and $135.17M in liabilities at the time. Its Book Value Per Share was -$2.24, while its Total Shareholder’s Equity was $410.47M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for INSM is Buy with a score of 5.00.
